The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
in Israel and Europe for research on artificial intelligence
in Europe and #21 in the world for aerospace engineering*
students
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesDiscover ways to support, connect, and help drive innovation.
Get InvolvedExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
Researchers have developed a unique technology using light to remotely control the cell’s internal stores of calcium. This elusive breakthrough could regulate the body’s immune system, potentially heading off disease, and control the sensation of pain.
Calcium is not only important for our bone strength, but it plays a key role in processes that control gene expression in our immune cells, muscle contraction, electrical transmission in the nervous system, and many other body functions. Abnormal changes of calcium levels in our cells can wreak havoc on the immune system and lead to various illnesses. As a result, a complex control system called store-operated calcium entry has developed through the course of evolution.
Science has shown that two different proteins, STIM and Orai, are at work in this system. STIM senses when the cell’s internal store of calcium is empty and communicates the information to Orai. The Orai protein then opens a channel in the cell membrane for calcium to enter and replenish the stockpile. Yet, mutation can cause break downs, a challenge that has vexed scientists for many years.
“Since this is a highly complex system that generates different calcium signals in different types of cells and also works alongside other calcium entry mechanisms … it is often very hard to study the role of this cellular machinery,” explained Technion Professor Raz Palty of the Rappaport Faculty of Medicine, who conducted the work with former Technion research associates Ronald Udasin and Elia Zomot, and in collaboration with groups headed by Technion Professor Yuval Shaked and Professor Michael Kienzler of the University of Connecticut.
The technology, published in PNAS, is based on an approach called photopharmacology — the activation of drugs that block calcium entry through Orai channels in the target tissue using light. Specifically, the researchers built a kind of “optical switch” that can be turned on and off to control when and where drugs introduced to the body are active. In this way, they regulate the level of calcium coming in through the Orai channel at a desired location and time. The study succeeded in modulating calcium entry in T lymphocytes, thereby regulating the production of cytokines. Managing cytokines is so crucial to the functioning of the immune system, that an uncontrolled and elevated release of the pro-inflammatory proteins can lead to advanced symptoms of COVID-19.
In a series of related experiments, researchers at Hebrew University of Jerusalem also found that manipulating the Orai-STIM system could control the sensation of pain. The scientists hope that these follow-up studies will provide a deeper understanding of the regulation mechanisms and broaden the clinical applications of their technology.
June 17, 2022
Researchers have developed a light-activated calcium control system that could regulate immune response and reduce pain.
1 min
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
What if diagnosing cancer, Parkinson’s disease, or other serious illnesses could be as simple as breathing into a handheld device? That possibility is moving closer to reality thanks to the work of the Technion’s Prof. Hossam Haick, whose groundbreaking research is changing how diseases are detected around the world. In recognition of his extraordinary achievements, […]
Every year, the European Research Council (ERC) identifies some of the world’s most promising early-career researchers and gives them the freedom to pursue bold ideas. This year, two of those ideas came from the Technion – Israel Institute of Technology. From cancer research to artificial intelligence (AI), breakthroughs that shape the future often begin with […]
As more people turn to AI chatbots for companionship, life advice, or even as a stand-in for therapy, experts say the technology offers both new opportunities and risks when it comes to mental health. Prof. Tanzeem Choudhury is the chief of health innovation in the Joan & Irwin Jacobs Technion-Cornell Institute and has been studying AI and mental health for 15 years. She said AI tools are available any time, often at low cost, making it easier for people to access some form of mental health support.
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.